ArticleCell communication and signaling : CCS2024

MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway.

Shengfeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.